Recombinant DLL3 (Rovalpituzumab Biosimilar) antibody

Catalog No. ABIN7488080

The Mammalian Cells Monoclonal anti-DLL3 (Rovalpituzumab Biosimilar) antibody has been validated for . It is suitable to detect DLL3 (Rovalpituzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant DLL3 (Rovalpituzumab Biosimilar) antibody (ABIN7488080)

Target: DLL3 (Rovalpituzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This DLL3 (Rovalpituzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-DLL3 (Rovalpituzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Rovalpituzumab Biosimilar - Anti-DLL3 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for DLL3 (Rovalpituzumab Biosimilar)

Target: DLL3 (Rovalpituzumab Biosimilar)

Target Type: Biosimilar